




已阅读5页,还剩23页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Hypertension In Chronic Kidney Disease,Renal disease,loss of nephrons,Systemic hypertension,Proteinuria,Progressive decline in GFR,Introduction,RENAL INJURY,Nephron mass Glomerular capillary hypertension Glomerular permeability to macromolecules Filtration of plasma proteins Proteinuria Excessive tubular protein reabsorbtion Tubulo-interstitial inflammation,RENAL SCARRING,SYSTEMIC HYPERTENSION,CKD: Common pathway in disease progression,Therapeutic intervention inhibiting this common pathway may succeed in slowing the rate of progression of CRF irrespective of the initiating cause,CKD: Common pathway in disease progression,Relative risk of ESRD according to quintile BP,MRFIT study N= 332,544 men,How important is systemic blood pressure control?,Treatment goal for hypertension in the general population has remained relatively the same for the last decade.,What should be the treatment goal?,Should be lower than the general population Should be tailored according to :,What should be the treatment goal for renal disease?,the severity of renal failure the severity of the proteinuria,Aggressive BP control to 125/75 mmHg showed better preservation of GFR for those with proteinuria 3g/day. No additional benefit if proteinuria is 1g/day,Klahr S, Levey AS: NEJM 1994; 330:877,Proteinuria and target BP control,What should be the treatment goal for renal disease?,Treatment goal should depend on the severity of proteinuria,What should be the treatment goal for non diabetic renal disease?,There is indisputable evidence from animal, laboratory and clinical studies that proteinuria per se contributes to progressive renal injury,Proteinuria,Proteinuria and renal disease progression,Klahr S, Levey AS: NEJM 1994; 330:877,Proteinuria and renal disease progression,REIN SUBSTUDY : Progression of renal disease according to severity of proteinuria,It is now clear that different classes of antihypertensive agents have different antiproteinuric capacity ACEI and ARB have been showed to exhibit the highest capacity to diminish protein excretion in urine,Proteinuria and renal disease progression,REIN Study : KIDNEY SURVIVAL,ACE Inhibitors In Nephropathy,P=0.04,REIN Study,ACE Inhibitors In Nephropathy,COOPERATE STUDY: Median urinary protein excretion,ACEI, ARB and combination treatment in Nephropathy,ACEI, ARB and combination treatment in Nephropathy,COOPERATE STUDY: proportion reaching endpoints,ACEI or ARB should be the first choice antihypertensive agent in patient with significant proteinuria.,Choice of antihypertensive agent for non diabetic renal disease,Dose of ACEI or ARB should be titrated to achieve both target BP and the disappearance of proteinuria,Choice of antihypertensive agent for non diabetic renal disease,If target blood pressure is not achieved and especially in the presence of persistent proteinuria, an ARB should be added.,Choice of antihypertensive agent for non diabetic renal disease,Check Cr and K+ within 7-14 days after starting treatment especially in the presence of renal impairment An acute rise in Cr of 30% should be tolerated if BP is adequately reduced (140/90), hyperkalaemia is absent and the patient is euvolaemic If Cr continues to rise, or hyperkalaemia persist, stop drugs; assess for bilateral RAS,Precautions when starting ACEI or ARB,Choice of combination antihypertensive agents depend on the existing comorbidity,Choice of antihypertensive agent for non diabetic renal disease,Drug(s) for the compelling indication,Choice of Anti-Hypertensive drugs in patient with concomitant disease,Since studies have demonstrated that most hypertensive patients will require multiple drugs to achieve target BP, the argument about which one is superior has become almost irrelevant We must provide all of the drugs ne
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025新外研版初中英语七年级下册知识点归纳总结(复习必背)
- 广州花都城投产融商业投资有限公司招聘考试真题2024
- 跨境电商人才招聘解决方案
- 长治急救知识培训班课件
- 难点解析-人教版八年级物理上册第4章光现象章节练习试题(解析卷)
- 山东注册环保工程师考试(大气污染防治专业案例)全真模拟题库及答案(2025年)
- 难点解析-人教版八年级物理上册第5章透镜及其应用-透镜单元测试试卷(详解版)
- 2025年燃气经营企业从业人员专业考试考前模拟试题及答案
- 2025金属非金属矿山主要负责人和安全生产管理人员考试综合练习题及答案
- 2025年煤矿安全生产管理人员安全生产知识和管理能力考试测试题及答案
- 【历年真题】2018年10月00688设计概论自考试卷
- 2023年浙江国科大杭州高等研究院招聘12人笔试参考题库(共500题)答案详解版
- 2023第八届全国学生学宪法讲宪法活动竞赛题库(汇总)
- GJB9001C-2017国军标标准培训讲义
- 《妇产科学课件:宫颈癌的筛查与防治》
- 服务型制造标准体系建设指南(2023年)征
- GA/T 2060-2023法庭科学毛发中甲基苯丙胺等11种毒品及代谢物检验液相色谱-质谱法
- 工程监理大纲监理方案服务方案
- C型钢检验报告
- 主体结构验收方案(示范文本)
- 八年级美术PPT课件 荷兰后印象派画家梵高作品介绍 《向日葵》《吃土豆的人》《割耳朵后的自画像》
评论
0/150
提交评论